Keywords
Carpal tunnel, pain, sensitization, nociceptive pain.
Carpal tunnel, pain, sensitization, nociceptive pain.
Carpal tunnel syndrome (CTS) is the most prevalent nerve compression disorder of the upper extremity, and it is generally associated with a localized compression of the median nerve in the carpal tunnel area. Although epidemiological data vary depending on the diagnostic criteria used, CTS has an incidence rate of 1.8/1,0001 and a prevalence rate ranging from 6.3 to 11.7% in the general population2. Since people affected by CTS are usually active workers, this condition is associated with substantial healthcare costs and economic burden3. Therefore, a better understanding of the potential underlying mechanisms of CTS could improve therapeutic strategies. This paper discusses current theories combining the presence of peripheral nociceptive barrage with the presence of altered nociceptive central processing and its repercussions for the potential management of CTS. The current paper is an updated version of a previous review on this topic4.
This review will try to answer the following questions: 1. is CTS just a localized peripheral entrapment of the median nerve? 2. What are the underlying mechanisms behind the clinical manifestations of CTS? 3. Does the presence of altered nociceptive gain potential have repercussions on treatment approaches in CTS?
The most common symptoms usually experienced by patients with CTS include pain and/or paresthesia in areas innervated by the median nerve, i.e. the thumb, index, and/or middle fingers. Symptoms can be worse during activities involving the hand/wrist but also at night. It seems that paresthesia, but not pain, is the symptom most commonly associated with neurophysiological damage of the median nerve5.
It is commonly seen in clinical practice that patients with CTS exhibit symptoms not only in those areas innervated by the median nerve but also in extra-median nerve areas. This was confirmed by Zanette et al., who observed that 35% of patients with CTS exhibit a glove distribution of their symptoms, whereas 5% exhibit an ulnar distribution6. The same authors also reported that 45% of CTS sufferers also report pain in proximal areas of the upper extremity including the elbow or the shoulder7. A more recent study, using new electronic software for analyzing pain extent, found that 88% of women with CTS showed extra-median pain symptoms8. The presence of spreading symptoms is a clinical manifestation of neuropathic but also nociceptive pain involving sensitization mechanisms and plasticity9. This hypothesis is confirmed by the fact that extra-median symptoms are not associated with electrical nerve conduction data, suggesting an association between neuropathic and nociceptive pain with expansion of receptive fields of central neurons in CTS10.
‘Sensitization’ is a term describing the changes in nociceptive neurons. It is mainly grouped into peripheral/central sensitization, and it is present in several musculoskeletal and neuropathic chronic pain conditions11,12. ‘Peripheral sensitization’ refers to increased responsiveness and reduced threshold of peripheral nociceptors; it is usually associated with the release of endogenous algogenic substances and neurogenic inflammation. ‘Central sensitization’ is defined by the International Association for the Study of Pain (IASP) as an increased responsiveness of the nociceptive neurons in the central nervous system to their normal or subthreshold afferent input, which may include increased responsiveness due to dysfunction of endogenous pain control systems13. The relationship between peripheral and central sensitization is well established. It is accepted that the presence of long-lasting and prolonged nociceptive peripheral inputs induces plastic changes in the central nervous system; therefore, central sensitization seems to be a dynamic process that is dependent on peripheral nociception11,12. In some patients, once central sensitization has been established, minimal peripheral nociception can be required to maintain this process and non-nociceptive inputs might also contribute to the subsequent pain and mechanical allodynia observed in this situation. Nevertheless, central sensitization is mainly driven by peripheral impulses. In such a scenario, in people with CTS, the entrapment of the median nerve at the carpal tunnel represents the peripheral input towards the central nervous system. Gracely et al. proposed this model for neuropathic pain in 1992 where peripheral nociception from an entrapped nerve could lead to neuroplastic changes in the central nervous system14. In CTS, the neurogenic inflammation of the median nerve induced by its entrapment can act as a peripheral driver for the gradual sensitization of nociceptive pathways. In fact, Truini et al. found that affectation of both nociceptive and non-nociceptive fibers contributed to the different symptoms experienced in CTS15.
The peripheral component of entrapment neuropathies such as CTS is supported by current literature16 and will not be further discussed in this text. In the last decade, different studies have investigated the presence of central sensitization by assessing widespread sensory disorders throughout quantitative sensory testing in CTS. Fernández-de-las-Peñas et al. found that women with strictly unilateral CTS symptoms exhibit widespread pressure pain sensitivity over the radial, ulnar, and median nerves, the cervical spine, and the tibialis anterior muscle, suggesting widespread hypersensitivity to pressure pain17. Widespread pressure hypersensitivity is a manifestation of the sensitization of central pathways; however, pressure pain hypersensitivity has also been found to be heterogeneously distributed in the symptomatic hand, supporting the relevant role of the peripheral input18. Similar results were also found by Zanette et al., who observed that CTS patients with extra-median symptoms exhibited generalized pressure hyperalgesia and enhanced wind-up19. Interestingly, widespread pressure pain hyperalgesia was not associated with the electrodiagnostic findings, since women with minimal, moderate, or severe CTS exhibit similar widespread sensory changes20. These results support the notion that widespread hyperalgesia to pressure pain can be a common manifestation of CTS from the beginning of symptom onset. In line with this hypothesis, Tampin, Vollert, and Schmid found that individuals with a peripheral neuropathy such as CTS exhibit similar sensory changes to those with a proximal (cervical) radiculopathy, although pain profiles were different21. Nevertheless, Schmid et al. did not observe widespread pressure hyperalgesia in patients with CTS without concomitant neck pain symptoms, suggesting that groups of patients with CTS could exist and that the observed widespread sensory changes can be more related to the presence of extra-median/proximal symptoms22. The hypothesis of different subgroups of patients with CTS has been supported by a study identifying a subgroup of women with CTS with higher bilateral widespread pressure hyperalgesia based on the presence of a cluster of symptoms23. Therefore, it is possible that CTS can be peripherally mediated in some patients but more centrally mediated in others.
The presence of central sensitization in CTS is also supported by imaging studies.
Tecchio et al. found that patients with CTS with symptoms of glove distribution exhibited an enlargement in cortical representation and neuroplastic changes in the somatosensory cortex compared to those individuals with just median nerve distribution symptoms24. Different studies have also shown larger contralateral sensorimotor cortical representation25 and smaller cortical source separation26 of the second/third digits in patients with CTS as compared to controls. All of these studies hypothesized that long-lasting paresthesia/pain symptoms (peripheral drive) can promote blurring of median nerve-innervated digit representations through neural mechanisms (central drive)25,26. There is also current evidence showing the presence of reduced endogenous inhibition and increased pain facilitation in patients with CTS27. In conclusion, long-lasting peripheral nociceptive stimuli originating in the median nerve could lead to neuroplastic changes in the central nervous system at both spinal cord and brainstem levels.
It is interesting to consider that sensitization mechanisms and sensory loss also have output manifestations. Motor control disturbances may be a perpetuating factor for pain since pain-related fear or avoidance behaviors can also promote negative attitudes. In addition, altered motor control patterns could reflect the reorganization of motor control strategies in the central nervous system, as sensory neuroplastic changes in the somatosensory cortex result in decreased fine motor control28. The presence of bilateral deficits in fine motor control and pinch grip force in women with strictly unilateral CTS supports this hypothesis29. Additionally, these bilateral deficits in fine motor control and pinch grip force were not associated with either median nerve damage or the presence of unilateral or bilateral symptoms30. Data suggest that motor output disorders are present from the onset of symptoms and could be related to neuroplastic changes in the cortex. Nevertheless, it is probable that peripheral and central mechanisms can be involved at the same time in the motor control disturbances observed in CTS.
Although CTS can be treated with conservative and surgical procedures, surgery continues to be the most common treatment approach proposed for these patients31. In fact, both open and endoscopic surgical interventions provide similar clinical results32. However, although surgery provides positive long-term results, it may not always be entirely successful33, and the recurrence rate is estimated to be around 30% (from 5 to 57%)34. There is great debate related to which patients with CTS should be treated with conservative or surgical treatment in the first instance35. In fact, no consensus exists on which therapeutic option is the best for CTS. A recent meta-analysis has reported that the differences between surgery and conservative treatment are small36. Interestingly, Jarvik et al. observed that 61% of patients with CTS attempted to avoid surgery37. Conservative treatment for CTS could be preferred as the first-line option for patients with minimal or moderate CTS, whereas surgery could be the first-line approach for patients with more severe symptoms or when conservative treatment has failed.
It is important to consider that there is no established algorithm for determining which patients with CTS will benefit from conservative treatment38, i.e. physiotherapy.
In fact, different meta-analyses reported inconclusive evidence for the use of different conservative interventions, such as low-level laser39, ultrasound40, or splinting41. Other conservative techniques, e.g. nerve/tendon (neuro-mobilization) gliding exercises, have shown promising, but also limited, outcomes42. Discrepancies in the effects of multiple and different management therapeutic strategies can be attributed to the fact that CTS is a heterogeneous syndrome. In such a scenario, the presence of sensitization mechanisms discussed in this text could provide a physiological explanation for those individuals with CTS who experience persistent symptoms despite apparently successful surgery.
A mechanism-based classification can help clinicians to understand that different signs and symptoms may reflect different underlying nociceptive gain mechanisms. The presence of sensitization mechanisms in people with CTS has potential implications for clinical practice, since it implies that, in some patients, more global, not just localized, interventions should be applied. According to current data, clinicians should identify if symptoms in a patient with CTS are mainly peripherally or centrally mediated. In patients with peripherally mediated symptoms, localized interventions targeting local tissue (i.e. median nerve entrapment at the carpal tunnel) should be provided. There is evidence supporting a peripheral effect of nerve/tendon gliding exercises in patients with CTS, since these exercises affect the biological integrity of the median nerve by increasing fluid dispersion and reducing intraneural edema43,44. In patients with centrally mediated symptoms, clinicians should incorporate therapeutic approaches directed at normalizing peripheral and central nervous system interactions (i.e. soft tissue-based techniques, nerve mobilizations, or pain neuroscience education) and not just localized interventions over the carpal tunnel. It is in this group of patients where medications targeting the central nervous system could be effective45.
This clinical reasoning has been applied in a randomized clinical trial comparing the effects of manual therapy including desensitization maneuvers of the central nervous system with surgery in women with CTS46. This promising clinical trial showed that the application of manual therapies following altered nociceptive gain reasoning exhibited better short-term (1- and 3-month) and similar long-term (6- and 12-month) effects on pain and function than surgery in women with CTS46. In fact, the cost-effectiveness analysis of this trial also revealed better economic aspects in favor of manual physical therapy47.
Nevertheless, the challenge facing clinicians is how to select the most appropriate intervention for each patient, who is likely to be slightly different in their presentation. To determine the most appropriate therapeutic strategy, considerations must be given to interpreting the clinical manifestations of these sensitization processes (peripheral and/or central) and to potential prognostic factors related to clinical outcomes. Nevertheless, although central sensitization has been related to poorer outcome in response to surgical or conservative treatment in musculoskeletal pain, this hypothesis is supported by small and exploratory studies, and no conclusion can be made for this assumption48. A recent study has reported that localized, but not widespread, pressure sensitivity was predictive of long-term clinical outcomes in a sample of women with CTS after the application of manual therapies including desensitization maneuvers of the central nervous system49. These preliminary results support the clinical reasoning that not all patients with CTS respond to the same therapeutic approach and subgroups of patients could exist.
This updated review of underlying mechanisms of CTS found that there is evidence supporting the presence of central sensitization mechanisms, potentially mediated by the peripheral nociceptive inputs from the median nerve, in patients presenting with CTS. The presence of central sensitization influences treatment prognosis and the response of patients with CTS to a particular therapeutic strategy. The current paper has proposed the existence of two main subgroups of patients: those with peripherally mediated CTS and those with centrally mediated CTS. Clinicians should apply therapeutic strategies based on current knowledge on pain neuroscience and according to the clinical presentation and predominant identified mechanisms in these patients.
Views | Downloads | |
---|---|---|
F1000Research | - | - |
PubMed Central
Data from PMC are received and updated monthly.
|
- | - |
Competing Interests: No competing interests were disclosed.
Competing Interests: No competing interests were disclosed.
Competing Interests: No competing interests were disclosed.
Alongside their report, reviewers assign a status to the article:
Invited Reviewers | |||
---|---|---|---|
1 | 2 | 3 | |
Version 1 15 Jun 20 |
read | read | read |
Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list:
Sign up for content alerts and receive a weekly or monthly email with all newly published articles
Already registered? Sign in
The email address should be the one you originally registered with F1000.
You registered with F1000 via Google, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Google account password, please click here.
You registered with F1000 via Facebook, so we cannot reset your password.
To sign in, please click here.
If you still need help with your Facebook account password, please click here.
If your email address is registered with us, we will email you instructions to reset your password.
If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance.
Comments on this article Comments (0)